Cannabinoid hyperemesis syndrome (CHS)
marijuana, Cannabinoid Hyperemesis Syndrome (CHS)
One of the biggest upcoming health concern that will be seen with legalizing marijuana is CHS. Chronic use of marijuana leads to CHS, which is “characterized by cyclical vomiting and compulsive bathing behaviors in chronic cannabis users” (Alberta Health Services, n.d.). Marijuana affects the brain and body leading to short-term, long-term health and mental health effects such as confusion, fatigue, decreased blood pressure, decreased memory and concentration, lung infections, and chronic cough (Health Canada, 2017). By legalizing marijuana health effects will be seen in the adolescent population. ”Younger persons have a higher rate of cannabis use and an increased risk for CHS (Ittner, 2016, p.3). Brian development takes place during the adolescent period and the cannabis affects brain development and function (Health Canada, 2017). Hence, legalizing marijuana indicates increased use resulting in increased health concerns such as addictions and mental health. There are currently no Alberta Health Services (AHS) patient handouts available after discharge regarding management of symptoms, prevention, and when to return to the emergency department. Staff awareness of the condition and treatment recommendations will aid in standardized and expedited care of patients.
Presented on April 23, 2018 at Student Research Day held at MacEwan University in Edmonton, Alberta.
All Rights Reserved